A phase II study of pazopanib as front-line therapy in...

A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy

Hirbe, Angela C., Eulo, Vanessa, Moon, Chang I., Luo, Jingqin, Myles, Stephanie, Seetharam, Mahesh, Toeniskoetter, Jacqui, Kershner, Tammy, Haarberg, Sasha, Agulnik, Mark, Monga, Varun, Milhem, Mohamm
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
137
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2020.06.016
Date:
September, 2020
File:
PDF, 1.02 MB
2020
Conversion to is in progress
Conversion to is failed